• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌肉量作为神经肌肉残疾儿童健康状况和功能的生物标志物:一项系统综述。

Muscle Mass as a Biomarker for Health Status and Function in Pediatric Individuals with Neuromuscular Disabilities: A Systematic Review.

作者信息

Ferrara Isabella R, Sadowsky Cristina L

机构信息

International Center for Spinal Cord Injury, Kennedy Krieger Institute, Baltimore, MD 21205, USA.

Department of Physical Medicine and Rehabilitation, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA.

出版信息

Children (Basel). 2024 Jul 3;11(7):815. doi: 10.3390/children11070815.

DOI:10.3390/children11070815
PMID:39062264
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11276588/
Abstract

This systematic review aims to investigate the relationship between muscle mass and specific health outcomes in pediatric populations with neuromuscular disorders. A search was performed for any relevant studies published in English from 1996 to 2023 in five databases. To be included in this analysis, articles must have had participants with an average age ≤21, focus on children with neuromuscular disabilities, and primarily examine relationships between muscle mass and any functional or health outcomes measure. Studies including typically developing children were used to contrast and enhance findings. Thirty-two studies were included, with 10,129 unique individuals represented: seventeen studies focused on healthy/typically developing children; seven on children with cerebral palsy; three on children with Duchenne muscular dystrophy; two on children with sarcopenia; and one study each on children with osteoporosis, congenital muscular dystrophy, and other various neurologic disorders. Thirteen studies assessed functional outcomes, ten assessed bone outcomes, and nine assessed other cardiovascular/metabolic outcomes. All of the included studies demonstrated relationships between muscle mass and respective outcomes in varying measures. The results of this review demonstrate that there is a consistently recognized relationship between muscle mass and important health outcomes in children, supporting clinically targeting muscle mass as a means to optimize desired outcomes.

摘要

本系统评价旨在研究神经肌肉疾病患儿群体中肌肉量与特定健康结局之间的关系。在五个数据库中检索了1996年至2023年以英文发表的任何相关研究。要纳入本分析,文章的参与者平均年龄必须≤21岁,关注神经肌肉残疾儿童,并主要研究肌肉量与任何功能或健康结局指标之间的关系。纳入发育正常儿童的研究用于对比和强化研究结果。共纳入32项研究,涉及10129名个体:17项研究关注健康/发育正常儿童;7项关注脑瘫儿童;3项关注杜氏肌营养不良症儿童;2项关注肌肉减少症儿童;另有1项研究分别针对骨质疏松症儿童、先天性肌营养不良症儿童和其他各种神经系统疾病儿童。13项研究评估了功能结局,10项评估了骨骼结局,9项评估了其他心血管/代谢结局。所有纳入研究均表明肌肉量与各自结局之间存在不同程度的关联。本评价结果表明,儿童的肌肉量与重要健康结局之间存在一直被认可的关系,支持临床上将肌肉量作为优化预期结局的一种手段。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4af9/11276588/214a565a0fc0/children-11-00815-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4af9/11276588/214a565a0fc0/children-11-00815-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4af9/11276588/214a565a0fc0/children-11-00815-g001.jpg

相似文献

1
Muscle Mass as a Biomarker for Health Status and Function in Pediatric Individuals with Neuromuscular Disabilities: A Systematic Review.肌肉量作为神经肌肉残疾儿童健康状况和功能的生物标志物:一项系统综述。
Children (Basel). 2024 Jul 3;11(7):815. doi: 10.3390/children11070815.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Respiratory muscle training in children and adults with neuromuscular disease.患有神经肌肉疾病的儿童和成人的呼吸肌训练
Cochrane Database Syst Rev. 2019 Sep 5;9(9):CD011711. doi: 10.1002/14651858.CD011711.pub2.
4
Glucocorticoid corticosteroids for Duchenne muscular dystrophy.用于杜氏肌营养不良症的糖皮质激素皮质类固醇
Cochrane Database Syst Rev. 2008 Jan 23(1):CD003725. doi: 10.1002/14651858.CD003725.pub3.
5
6
Walking and weakness in children: a narrative review of gait and functional ambulation in paediatric neuromuscular disease.儿童行走和无力:儿科神经肌肉疾病步态和功能性步行的叙述性综述。
J Foot Ankle Res. 2020 Mar 2;13(1):10. doi: 10.1186/s13047-020-0378-2.
7
Basics of bone metabolism and osteoporosis in common pediatric neuromuscular disabilities.儿童常见神经肌肉疾病中的骨代谢与骨质疏松基础。
Eur J Paediatr Neurol. 2018 Jan;22(1):17-26. doi: 10.1016/j.ejpn.2017.08.001. Epub 2017 Aug 10.
8
Glucocorticoid corticosteroids for Duchenne muscular dystrophy.用于杜氏肌营养不良症的糖皮质激素皮质类固醇
Cochrane Database Syst Rev. 2004(2):CD003725. doi: 10.1002/14651858.CD003725.pub2.
9
A comprehensive normative reference database of muscle morphology in typically developing children aged 3-18 years-a cross-sectional ultrasound study.一项针对3至18岁正常发育儿童肌肉形态的综合规范性参考数据库——横断面超声研究。
J Anat. 2023 May;242(5):754-770. doi: 10.1111/joa.13817. Epub 2023 Jan 17.
10

本文引用的文献

1
Skeletal muscle mass, muscle strength, and physical performance in children and adolescents with obesity.肥胖青少年的骨骼肌量、肌肉力量和身体机能。
Front Endocrinol (Lausanne). 2023 Oct 4;14:1252853. doi: 10.3389/fendo.2023.1252853. eCollection 2023.
2
Challenges and physiological implications of sarcopenia in children and youth in health and disease.儿童和青少年健康与疾病中肌肉减少症的挑战和生理影响。
Curr Opin Clin Nutr Metab Care. 2023 Nov 1;26(6):528-533. doi: 10.1097/MCO.0000000000000969. Epub 2023 Aug 2.
3
Decrease of Muscle Mass in Young Patients With Neuromuscular Disease: Assessment of Sarcopenia.
年轻神经肌肉疾病患者肌肉质量减少:肌少症评估。
J Korean Med Sci. 2023 May 29;38(21):e187. doi: 10.3346/jkms.2023.38.e187.
4
Targeting Sarcopenia as an Objective Clinical Outcome in the Care of Children with Spinal Cord-Related Paralysis: A Clinician's View.将肌肉减少症作为脊髓相关瘫痪儿童护理的客观临床结果:临床医生的观点
Children (Basel). 2023 May 5;10(5):837. doi: 10.3390/children10050837.
5
Influence of puberty on relationships between body composition and blood pressure: a cross-sectional study.青春期对体成分与血压之间关系的影响:一项横断面研究。
Pediatr Res. 2023 Aug;94(2):781-788. doi: 10.1038/s41390-023-02503-7. Epub 2023 Feb 7.
6
Body Composition in Outpatient Children with Cerebral Palsy: A Case-Control Study.门诊脑瘫患儿的身体成分:一项病例对照研究。
Int J Gen Med. 2023 Jan 24;16:281-291. doi: 10.2147/IJGM.S393484. eCollection 2023.
7
Association of gross motor function and activities of daily living with muscle mass of the trunk and lower extremity muscles, range of motion, and spasticity in children and adults with cerebral palsy.脑瘫儿童和成人的粗大运动功能及日常生活活动与躯干和下肢肌肉质量、关节活动范围及痉挛的相关性
Dev Neurorehabil. 2023 Feb;26(2):115-122. doi: 10.1080/17518423.2023.2171149. Epub 2023 Jan 30.
8
Assessment of body composition by whole-body densitometry: what radiologists should know.通过全身密度测定法评估身体成分:放射科医生应了解的内容。
Radiol Bras. 2022 Sep-Oct;55(5):305-311. doi: 10.1590/0100-3984.2021.0155-en.
9
Fat-Free Mass Index as a Surrogate Marker of Appendicular Skeletal Muscle Mass Index for Low Muscle Mass Screening in Sarcopenia.无脂肪质量指数作为用于筛查肌少症中低肌肉量的四肢骨骼肌质量指数的替代标志物。
J Am Med Dir Assoc. 2022 Dec;23(12):1955-1961.e3. doi: 10.1016/j.jamda.2022.08.016. Epub 2022 Sep 28.
10
Sarcopenic Obesity in Children and Adolescents: A Systematic Review.儿童和青少年的肌肉减少性肥胖:系统综述。
Front Endocrinol (Lausanne). 2022 Jun 1;13:914740. doi: 10.3389/fendo.2022.914740. eCollection 2022.